Prevalence of Chronic Non-Communicable Respiratory Diseases in Mosul City

Main Article Content

Radhwan Hussein Ibrahim
Ahmed Abdulrazzaq Malallah Al-Nuaimy

Abstract

Introduction: Chronic non-communicable respiratory diseases (CNCRDs) encompass a group of conditions affecting the airways and lung structures, including Chronic Obstructive Pulmonary Disease (COPD), emphysema, allergic rhinitis, asthma, pulmonary arterial hypertension, and cystic fibrosis. CNCRDs pose a significant global health challenge, resulting in approximately four million deaths annually. This study aimed to identify the prevalence and risk factors associated with CNCRDs and measure trends in the prevalence of these risk factors over time. Methods: A cross-sectional epidemiological study was conducted using data collected from primary health centers on both sides of Mosul City. The study period extended from January 1 to July 31, 2022, with information obtained from (40) primary health centers, consisting of (20) centers on the right side and (20) centers on the left side of Mosul. Results: In 2021, the City of Mosul recorded a total of 13,005 registered cases, with 5,598 cases being attributed to asthma (43%), and 7,347 cases being associated with COPD (57%). Bronchial asthma constituted 43% of cases, with 5598 patients, and the highest incidence occurred in the age group between 20-44 years. Conclusion: The prevalence of bronchial asthma and COPD among patients with CNCRDs in Mosul is alarmingly high. It emphasizes the importance of implementing preventive policies and strategies targeting modifiable risk factors for these respiratory conditions.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ibrahim, R. H., & Malallah Al-Nuaimy, A. A. (2024). Prevalence of Chronic Non-Communicable Respiratory Diseases in Mosul City. Malaysian Journal of Medicine and Health Sciences, 20(1), 205–211. https://doi.org/10.47836/mjmhs.20.1.27
Section
Original Articles

References

Abbaszadeh H, Ghorbani F, Abbaspour- Aghdam S, Kamrani A, Valizadeh H, Nadiri M, et al. Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools. Stem Cell Research & Therapy. 2022;13(1):1-15. doi:10.1186/s13287-022-02938-5

Khadyer AY, Ahmed SA. Evaluation of nurses’ practice concerning pulmonary rehabilitation to remove secretions from the lungs of a person infected with COVID-19. Mosul Journal of Nursing. 2023;11(2):282-91.

Korzh O, Collaborators GCRD. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. 2023.

Abdelfatah Alhoot M, YM Mai M, Purwitasari N, K Gunasekaran K, Shamsul Rodzi NI, Nasrin Kader Mohideen Z, et al. META-ANALYSIS STUDY: NASOPHARYNGEAL SWABS ARE MORE SENSITIVE THAN OROPHARYNGEAL SWABS IN THE DETECTION OF THE VIRAL

GENOME OF SARS-CoV-2. Mosul Journal of Nursing. 2023;11(1):97-103. doi:10.33899/ mjn.2023.176962

Tabyshova A. Prevalence, socio-economic burden and pharmacologic treatment of COPD in Kyrgyzstan. 2022.

Yahya BA, Saad DN, Ali SH. The effect of age and gender on the severity of coronavirus infection. Mosul Journal of Nursing. 2022;10(2):169-74. doi: 10.33899/mjn.2022.174938

Moslemi A, Kontogianni K, Brock J, Wood S, Herth

F, Kirby M. Differentiating COPD and asthma using quantitative CT imaging and machine learning. European Respiratory Journal. 2022;60(3). doi:10.1183/13993003.03078-2021

Parikh S, Henderson K, Gondalia R, Kaye L, Remmelink E, Thompson A, et al. Perceptions of environmental influence and environmental information-seeking behavior among people with asthma and COPD. Frontiers in Digital Health. 2022; 4:748400. doi:10.3389/fdgth.2022.748400

Bhat AH, Hussain A. Prevalence of Comorbidities Among COPD Patients: A Comparative Case- Control Study in Kashmir.

Bonnesen B, Sivapalan P, Jordan A, Pedersen JW, Bergsøe CM, Eklöf J, et al. Risk of malignancy in patients with asthma-COPD overlap compared to patients with COPD without asthma. Biomedicines. 2022;10(7):1463. doi:10.3390/ biomedicines10071463

Buklioska Ilievska D, Minov J, Ivana M. Diabetes mellitus type 2 (T2D) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD). 2022. doi:10.1183/13993003.congress-2021.PA2236

Huang K, Chung KF, Yang T, Xu J, Yang L, Zhao J, et al. Chronic obstructive pulmonary disease with asthma-like features in the general population in China. Frontiers in Medicine. 2022; 9:876240. doi:10.3389/fmed.2022.876240

Barn P, Rideout KL, Lo W, Josey D, Vint Z, Sha C, et al. Better together: launching and nurturing a community Stakeholder committee to enhance care and research for asthma and COPD. Chest. 2022;161(2):382-8. doi: 10.1016/j. chest.2021.10.028

Gleeson PK, Morales KH, Hvisdas C, LaCava AF, Harhay MO, Rank MA, et al. Factors Associated with Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(6):1834-42. e4. doi:10.1016/j. jaip.2023.03.003

Aït-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bulletin of the World Health Organization. 2001; 79:971-9.

Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. International journal for equity in health. 2005; 4:1-8. doi:10.1186/1475-9276-4-2

Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clinics in chest medicine. 2004;25(2):331-41. doi:10.1016/j.ccm.2004.01.003

Cunningham TJ, Ford ES, Croft JB, Merrick MT, Rolle IV, Giles WH. Sex-specific relationships between adverse childhood experiences and chronic obstructive pulmonary disease in five states. International journal of chronic obstructive

pulmonary disease. 2014:1033-43. doi:10.2147/ COPD.S68226

Abramson MJ, Perret JL, Dharmage SC, McDonald VM, McDonald CF. Distinguishing adult-onset asthma from COPD: a review and a new approach. International journal of chronic obstructive pulmonary disease. 2014:945-62. doi:10.2147/ COPD.S46761

Melén E, Guerra S, Hallberg J, Jarvis D, Stanojevic

S. Linking COPD epidemiology with pediatric asthma care: implications for the patient and the physician. Pediatric Allergy and Immunology. 2019;30(6):589-97. doi:10.1111/pai.13054

James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. American journal of respiratory and critical care medicine. 2005;171(2):109-14.

doi:10.1164/rccm.200402-230OC

Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. American journal of respiratory and critical care medicine. 2002;166(5):675-9. doi:10.1164/rccm.2112096

Lindberg A, Jonsson A-C, Rönmark E, Lundgren R, Larsson L-G, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005;127(5):1544-52. doi:10.1378/

chest.127.5.1544

Alif SM, Dharmage SC, Benke G, Dennekamp M, Burgess JA, Perret JL, et al. Occupational exposure to pesticides are associated with fixed airflow obstruction in middle-age. Thorax. 2017;72(11):990-7. doi:10.1136/

thoraxjnl-2016-209665